ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
-
Bid
-
Ask
-
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
-
Open
-
Last Trade
Last Trade Time
-
Average Volume (3m)
-
Financial Volume
-
VWAP
-

GILD Latest News

Gilead Stops Development of Lung Drug Cicletanine After Missing Study Goal

By Peter Loftus Gilead Sciences Inc. (GILD) has discontinued development of a treatment for a rare lung disease after it failed to meet its efficacy goal in a clinical trial. The drug...

Seven Summits Research Releases Comments on Microsoft, Amazon.com, Celgene, Starwood Hotels and Gilead Sciences

CHICAGO, Oct. 19 /PRNewswire/ -- Seven Summits Strategic Investments releases its Stocks To Watch Guide. The Seven Summits Strategic Investments Stocks To Watch Guide (go to:...

US EQUITIES WEEK AHEAD: More 3Q Results; Windows 7 Launches

Boeing Co. (BA), DuPont Co. (DD), Pfizer Inc. (PFE) and Microsoft Corp. (MSFT) are among the major companies posting quarterly results next week. Meanwhile, economic reports are expected to show...

Critical Alerts for US Steel, Gilead, Dow Chemical, Banco Bradesco, and Marvel Entertainment Released by Seven Summits Research

CHICAGO, Oct. 5 /PRNewswire/ -- Seven Summits Research issues PriceWatch Alerts for X, GILD, DOW, BBD, and MVL. Seven Summits Strategic Investments' PriceWatch Alerts are available at...

Gilead: US Requests Documents About Angina Drug

By Carla Mozee Biotech firm Gilead Sciences Inc. (GILD) said Friday that it has received a subpoena from the U.S. Department of Health and Human Services requesting documents about the...

MARKET SNAPSHOT: As Earnings Doubts Fade, Stocks Set Sights On GDP

By Nick Godt With any concerns about the second-quarter earnings season mostly behind, the market will now key on more signs of "green shoots" in big economic reports, starting with the...

UPDATE: Gilead Sciences 2Q Profit Up 31% On HIV Drug Sales

Gilead Sciences Inc.'s (GILD) second-quarter profit climbed 31% on strong sales of its core HIV treatment franchise, but its disappointing revenue outlook sent shares lower. The Foster City...

Gilead Projects 2009 Net Product Revenue $6.1 Billion-$6.2 Billion

Gilead Sciences Inc. (GILD) raised its projection for 2009 net product revenue to $6.1 billion to $6.2 billion in its first update since April's $1.4 billion acquisition of CV Therapeutics. The...

Gilead Sciences 2Q Profit Up 31% On Higher HIV Product Sales

Gilead Sciences Inc.'s (GILD) second-quarter profit climbed 31% as the biopharmaceutical company reported higher sales from its HIV products and added revenue from its acquisition of heart-drug...

Gilead Sciences Files Patent Infringements Suit Against Teva

Gilead Sciences Inc. (GILD) said on Thursday it filed a lawsuit against Israeli-based Teva Pharmaceutical Industries Inc. (TEVA) and its U.S. subsidiary for infringement of two patents tied to two...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

GILD - Frequently Asked Questions (FAQ)

What is the current Gilead Sciences share price?
The current share price of Gilead Sciences is 0.00 €
What is the 1 year trading range for Gilead Sciences share price?
Gilead Sciences has traded in the range of 0.00 € to 0.00 € during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
WS3D25Solid World Group spa
0.2486 €
(38.11%)
61.48k
WNUS26Nusco Spa
0.1344 €
(29.73%)
9k
1CVACCureVac BV
4.952 €
(24.92%)
12.8k
WERFOLaboratorio Farmaceutico Erfo SPA
0.0499 €
(20.53%)
1,000
WRKT25Roket Sharing Company Spa
0.003 €
(20.00%)
91.88k
WAMB26Ambromobiliare SpA
0.064 €
(-28.89%)
10k
1NKLANikola Corp
1.4642 €
(-11.26%)
32.07k
UBAUbaldi Costruzioni SPA
3.9995 €
(-10.32%)
11.2k
ELBEdgelab
6.70 €
(-9.46%)
14k
EVAAskoll Eva SPA
0.1455 €
(-8.49%)
150k
TITTelecom Italia SpA
0.2547 €
(4.39%)
192.95M
ISPIntesa Sanpaolo Spa
3.924 €
(-0.14%)
37.82M
TITRTelecom Italia
0.2999 €
(3.92%)
24.85M
SPMSaipem Spa
2.708 €
(-1.46%)
20.2M
BPEBper Banca SPA
6.11 €
(1.70%)
11.07M

Discussion

View Full Feed
jour_trader jour_trader 4 minutes ago
Thanks. Meant to provide that months ago and just didn't have time to dig in. Some cases that had a couple similar patents infringed (Amneal) were settled. Docs are behind a paywall so haven't seen specific details there. 
ELTP
jimmybob jimmybob 4 minutes ago
$TDOC back over its 200dma - it is still January last I checked so January effect is still in effect

I think that rhymes btw
TDOC
FeMike FeMike 4 minutes ago
Why do you need to lie to disparage the presentation?

I don't.

The presentation does that for itself.

Presenting the failed original primary endpoint data as the first results slide was an egregious offense to shareholders. Should never have happened.
NWBO
Doubledown75 Doubledown75 4 minutes ago
CFTC chair Benham resigned;)
AABB
doc2016 doc2016 4 minutes ago
the nvda miniaturized supercomputer named thor is n the cloud or on the device. 'and/or'?does drive os send realtime data to the learning module during the course of operation?
call winning, thor seems like a very much more powerful mpc 555 telematics device. it likely has facets of the vc
Teddytropics Teddytropics 4 minutes ago
That's the plan..

Come on the SEC...

Allow them run...
CNNA
rbtree rbtree 5 minutes ago
15.92!!!!!!!!!!!!!!!!!!!! 7 minutes after open!
ENVX
DiscoverGold DiscoverGold 5 minutes ago
Today Disney (Walt) Company. (DIS) is the best performer in the DJIA
By: Thom Hartle | January 7, 2025

• Today (8:32 CST), the best performer in the DJIA is Disney (Walt) Company. DIS.

pbs.twimg.com/media/Ggsonp1WoAEzWfr?format=jpg&name=900x900
DIS
pos_stock_hoarder pos_stock_hoarder 5 minutes ago
And truthful too! If I go to a doctor or dentist, the waiting room MAYBE has one other person besides me reading a book! And I don't mean and e-book! LOL!
STOCKMONSTER STOCKMONSTER 5 minutes ago
WORD SALAD FROM NVDA!!!!!!!!!!!!!!!!!!!!!!! NO DIRECTION!!!!!!!!! JUST A NUNCH OF INCOHERENT MUMBO JUMBO!!!!!!!!!!!!!! SORRY TO THE FOLKS WHO HAVE THEIR LIFE SAVINGS IN THIS!!!!!!!!!!!!!!!!!! POSSIBLW BREAK DOWN TO 115 BUCKS!!!!!!! MUAHAHAHHAHAH!!!!!!
NVDA
powerwalker powerwalker 5 minutes ago
Roger, what is going on with you and your ohtuvayre experience?

We would like to hear about it.
VRNA
RIGATONI RIGATONI 5 minutes ago
.074 cleared, lovely ~Rig
Starlost Starlost 5 minutes ago
Not yet...2's back on the bid...ugh.
TKMO
JamesF1 JamesF1 5 minutes ago
Purdue (Knoa) has way too much baggage to buy anything right now. Elite will be sold, but to a much better company. JMHO
ELTP
cottonmather cottonmather 5 minutes ago
Chris Vermeulen/ Market top? Good video. 23 minutes. https://youtu.be/C11ylP044AM?si=l45XaM1N7m8flt-Q
work-n-hard work-n-hard 5 minutes ago
PLUG: 3.2
NoMoDo NoMoDo 6 minutes ago
I think it is safe to say that I have read the filings. You, on the other hand are fos. The B conversions from Grado severely hurt the company, but he turned out to not be a friend or family member. He was the main guy who created the blocks tech. He took his money and ran. The biggest insider
HMBL
RobotDroid RobotDroid 6 minutes ago
The word of the day, week, and month is RED.
NWBO
BigBadWolf BigBadWolf 6 minutes ago
All need to learn [yt]Wxk1cyYJe-o[/yt]
nor converse w/ much less bring attention to any of their damn post
RDAR
AKATITUS AKATITUS 6 minutes ago
😄 🤣 😂
FUBO
TheKid5 TheKid5 6 minutes ago
Patience .....Before second quarter, for sure
CLNV
rbtree rbtree 7 minutes ago
22.20, four minutes after the open!!!
LUNR
sab63090 sab63090 7 minutes ago
boi568
He probably is correct about a second trial (I really don't know one way or the other), but surely Missling stated that he will need assistance because of the cost of that....I was always sold on: conditional approval with an ongoing trial (Phase 4).
AVXL
10thMountain 10thMountain 7 minutes ago
So what happened here?
HLLK